Chemoinformaics analysis of 3-Indoleacetonitrile
Molecular Weight | 156.188 | nRot | 1 |
Heavy Atom Molecular Weight | 148.124 | nRig | 11 |
Exact Molecular Weight | 156.069 | nRing | 2 |
Solubility: LogS | -2.435 | nHRing | 1 |
Solubility: LogP | 1.791 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 2 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 20 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 1 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 1 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 2 | No. of Arom Atom | 9 |
No. of Oxygen atom | 0 | No. of Arom Bond | 10 |
nHA | 1 | APOL | 24.2343 |
nHD | 1 | BPOL | 9.16566 |
QED | 0.675 |
Synth | 2.048 |
Natural Product Likeliness | -0.359 |
NR-PPAR-gamma | 0.005 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.001 |
Pgp-sub | 0.016 |
HIA | 0.005 |
CACO-2 | -4.465 |
MDCK | 0.0000203 |
BBB | 0.957 |
PPB | 0.6609 |
VDSS | 1.414 |
FU | 0.326232 |
CYP1A2-inh | 0.985 |
CYP1A2-sub | 0.772 |
CYP2c19-inh | 0.648 |
CYP2c19-sub | 0.06 |
CYP2c9-inh | 0.159 |
CYP2c9-sub | 0.896 |
CYP2d6-inh | 0.345 |
CYP2d6-sub | 0.415 |
CYP3a4-inh | 0.266 |
CYP3a4-sub | 0.205 |
CL | 9.416 |
T12 | 0.886 |
hERG | 0.021 |
Ames | 0.55 |
ROA | 0.895 |
SkinSen | 0.298 |
Carcinogencity | 0.165 |
EI | 0.98 |
Respiratory | 0.986 |
NR-Aromatase | 0.826 |
Antiviral | No |
Prediction | 0.745935 |